---
figid: PMC5641118__oncotarget-08-72147-g001
figtitle: Drug repositioning of mevalonate pathway inhibitors as antitumor agents
  for ovarian cancer
organisms:
- Homo sapiens
- Mus musculus
- Bos taurus
- Diaporthe sclerotioides
- Betapolyomavirus macacae
organisms_ner:
- NA
pmcid: PMC5641118
filename: oncotarget-08-72147-g001.jpg
figlink: /pmc/articles/PMC5641118/figure/F1/
number: F1
caption: . Selected schema of the mevalonate pathway with inhibitors used in this
  study.
papertitle: Drug repositioning of mevalonate pathway inhibitors as antitumor agents
  for ovarian cancer.
reftext: Yusuke Kobayashi, et al. Oncotarget. 2017 Sep 22;8(42):72147-72156.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8127593
figid_alias: PMC5641118__F1
figtype: Figure
redirect_from: /figures/PMC5641118__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5641118__oncotarget-08-72147-g001.html
  '@type': Dataset
  description: . Selected schema of the mevalonate pathway with inhibitors used in
    this study.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Geranylgeranyl-Pyrophosphate
  - Farnesyl-Pyrophosphate
  - 3-hydroxy-3-methylglutaryl-coenzyme A
  - Acetoacetyl-coenzyme A
  - 6-Fluoromevalonate
  - Mevalonate Pyrophosphate
  - Lonafarnib
  - YM-53601
  - Cholesterol
  - Bisphosphonate
  - Mevalonic Acid
  - Squalene
---
